Skip to main content

Table 1 Clinical characteristics and cardiovascular treatment at baseline. Plus/minus values are means ± SD.

From: Impact of obstructive sleep apnea on the occurrence of restenosis after elective percutaneous coronary intervention in ischemic heart disease

 

Control n = 43

OSA n = 35

p

Age (y)

65.1 ± 9.6

67.4 ± 7.3

0.17

Male n (%)

39 (90.7)

32 (91.4)

0.66

BMI (kg/m2)

27.9 ± 4.6

28.1 ± 4.0

0.82

AHI (events/h)

3.8 ± 2.5

27.5 ± 16.6

< 0.001

Min SaO2 (%)

89.3 ± 3.2

83.8 ± 4.0

< 0.001

Medication

   

Platelet inhibitor, n (%)

40 (93)

33 (94.3)

0.82

Beta Blocker, n (%)

33 (76)

25 (71.4)

0.59

ACE Inhibitor, n (%)

30 (69.8)

25 (71.4)

0.87

Statin, n (%)

34 (79.1)

26 (74.3)

0.62